reduce insulin dose when starting glp-1 receptor agonist agonists GLP-1 Receptor Agonists: An Alternative
Description
doi: 10.1016/S1474-4422(15)00141-6 51 ZhengMWangP
Hidden costs to factor in The vial price is not the complete cost
C., Tavares, C
This review outlines the mechanistic pathways through which GLP-1 RAs influence BP, summarizes RCT evidence across relevant populations, and discusses implications for clinical practice and future research
TABLE 4 Signal strength for GLP-1 receptor agonists based on PT level in FAERS
